Brief: Acrux Gets U.S. FDA Approval For Generic Version Of EMLA Cream
28/07/2021 02:14
July 28 (Reuters) - Acrux Ltd ACR.AX :
* ACRUX RECEIVES THIRD FDA ANDA APPROVAL
* GETS US FDA APPROVAL FOR GENERIC VERSION OF EMLA CREAM
Source text for Eikon: ID:nASX9LkC2Z
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share